These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 34898481)

  • 1. Emergence of Novel SARS-CoV-2 variants in India: second wave.
    Adiga R; Nayak V
    J Infect Dev Ctries; 2021 Nov; 15(11):1578-1583. PubMed ID: 34898481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.
    Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA
    J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.
    Díez-Fuertes F; Iglesias-Caballero M; García-Pérez J; Monzón S; Jiménez P; Varona S; Cuesta I; Zaballos Á; Jiménez M; Checa L; Pozo F; Pérez-Olmeda M; Thomson MM; Alcamí J; Casas I
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33127745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of SARS-CoV-2 variants of concern (VOC) in Bangladesh during the first half of 2021.
    Afrin SZ; Islam MT; Paul SK; Kobayashi N; Parvin R
    Virology; 2022 Jan; 565():29-37. PubMed ID: 34700068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-emergence of Gamma-like-II and emergence of Gamma-S:E661D SARS-CoV-2 lineages in the south of Brazil after the 2021 outbreak.
    Oliveira MM; Schemberger MO; Suzukawa AA; Riediger IN; do Carmo Debur M; Becker G; Resende PC; Gräf T; Balsanelli E; de Baura VA; de Souza EM; Pedrosa FO; Alves LR; Blanes L; Nardelli SC; Aguiar AM; Albrecht L; Zanette D; Ávila AR; Morello LG; Marchini FK; Dos Santos HG; Passetti F; Dallagiovanna B; Faoro H
    Virol J; 2021 Nov; 18(1):222. PubMed ID: 34789293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of SARS-CoV-2 clades based on signature SNPs unveils continuous evolution.
    Ghosh N; Saha I; Nandi S; Sharma N
    Methods; 2022 Jul; 203():282-296. PubMed ID: 34547443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Characterization of an Emerging SARS-CoV-2 Variant During the Early Second Wave of the SARS-CoV-2 Pandemic in Maharashtra, India.
    Karyakarte RP; Das R; Joshi S; Jayaram A; Yanamandra S; Shende S; Taji N; Rane S; Bawale R; Chaudhari GP; Karekar B; Sakalkar SR; Tiwari RG; Jadhav MG
    Cureus; 2023 Nov; 15(11):e48604. PubMed ID: 38090396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative Consolidation of the Kappa Variant Pre-Dates the Massive Second Wave of COVID-19 in India.
    Singh J; Malhotra AG; Biswas D; Shankar P; Lokhande L; Yadav AK; Raghuvanshi A; Kale D; Nema S; Saigal S; Singh S
    Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of European and North American mutant variants of SARS-CoV-2 in South-East Asia.
    Islam OK; Al-Emran HM; Hasan MS; Anwar A; Jahid MIK; Hossain MA
    Transbound Emerg Dis; 2021 Mar; 68(2):824-832. PubMed ID: 32701194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of R.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with spike protein W152L/E484K/G769V mutations in Japan.
    Hirotsu Y; Omata M
    PLoS Pathog; 2021 Jun; 17(6):e1009619. PubMed ID: 34097716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 genome surveillance: A geographical landscape and mutational mapping of SARS-CoV-2 variants in central India over two years.
    Khairnar K; Tomar SS
    Virus Res; 2024 Jun; 344():199365. PubMed ID: 38527669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Analysis of SARS-CoV-2 Circulating in Bangladesh during 2020 Revealed Lineage Diversity and Potential Mutations.
    Parvin R; Afrin SZ; Begum JA; Ahmed S; Nooruzzaman M; Chowdhury EH; Pohlmann A; Paul SK
    Microorganisms; 2021 May; 9(5):. PubMed ID: 34065789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phylogenomics and population genomics of SARS-CoV-2 in Mexico during the pre-vaccination stage reveals variants of interest B.1.1.28.4 and B.1.1.222 or B.1.1.519 and the nucleocapsid mutation S194L associated with symptoms.
    Barona-Gómez F; Delaye L; Díaz-Valenzuela E; Plisson F; Cruz-Pérez A; Díaz-Sánchez M; García-Sepúlveda CA; Sanchez-Flores A; Pérez-Abreu R; Valencia-Valdespino FJ; Vega-Magaña N; Muñoz-Valle JF; García-González OP; Bernal-Silva S; Comas-García A; Cibrián-Jaramillo A
    Microb Genom; 2021 Nov; 7(11):. PubMed ID: 34846283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity.
    Raghav S; Ghosh A; Turuk J; Kumar S; Jha A; Madhulika S; Priyadarshini M; Biswas VK; Shyamli PS; Singh B; Singh N; Singh D; Datey A; Avula K; Smita S; Sabat J; Bhattacharya D; Kshatri JS; Vasudevan D; Suryawanshi A; Dash R; Senapati S; Beuria TK; Swain R; Chattopadhyay S; Syed GH; Dixit A; Prasad P; ; ; Pati S; Parida A
    Front Microbiol; 2020; 11():594928. PubMed ID: 33329480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Dominance of Severe Acute Respiratory Syndrome Coronavirus 2 B.1.617 and Its Sublineages and Associations with Mortality during the COVID-19 Pandemic in India between 2020 and 2021.
    Venkatraja B; Srilakshminarayana G; Krishna Kumar B
    Am J Trop Med Hyg; 2021 Nov; 106(1):142-149. PubMed ID: 34788739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic analysis of SARS-CoV-2 reveals local viral evolution in Ghana.
    Ngoi JM; Quashie PK; Morang'a CM; Bonney JH; Amuzu DS; Kumordjie S; Asante IA; Bonney EY; Eshun M; Boatemaa L; Magnusen V; Kotey EN; Ndam NT; Tei-Maya F; Arjarquah AK; Obodai E; Otchere ID; Bediako Y; Mutungi JK; Amenga-Etego LN; Odoom JK; Anang AK; Kyei GB; Adu B; Ampofo WK; Awandare GA
    Exp Biol Med (Maywood); 2021 Apr; 246(8):960-970. PubMed ID: 33325750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome sequence diversity of SARS-CoV-2 in Serbia: insights gained from a 3-year pandemic study.
    Novkovic M; Banovic Djeri B; Ristivojevic B; Knezevic A; Jankovic M; Tanasic V; Radojicic V; Keckarevic D; Vidanovic D; Tesovic B; Skakic A; Tolinacki M; Moric I; Djordjevic V
    Front Microbiol; 2024; 15():1332276. PubMed ID: 38476954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation Analysis of SARS-CoV-2 Variants Isolated from Symptomatic Cases from Andhra Pradesh, India.
    Nagaraja M; Sireesha K; Srikar A; Sudheer Kumar K; Mohan A; Vengamma B; Tirumala C; Verma A; Kalawat U
    Viruses; 2023 Jul; 15(8):. PubMed ID: 37631999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 genome variations and evolution patterns in Egypt: a multi-center study.
    Jalal D; Elzayat MG; El-Shqanqery HE; Diab AA; Yahia A; Samir O; Bakry U; Amer K; ElNaqeeb M; Hassan W; Talat HS; Farawela HM; Hamdy MS; Soliman MS; El Sissy MH; Ezzelarab MH; El Khateeb SM; Soliman LH; Haddad SE; Hatem A; Ismail MS; Hossam M; Mansour T; Shalaby L; Soliman S; Hassan R; Hammad M; Abdo I; Magdeldin S; ElHaddad A; Abouelnaga S; Sayed AA
    Sci Rep; 2022 Aug; 12(1):14511. PubMed ID: 36008511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 clade dynamics and their associations with hospitalisations during the first two years of the COVID-19 pandemic.
    Päll T; Abroi A; Avi R; Niglas H; Shablinskaja A; Pauskar M; Jõgeda EL; Soeorg H; Kallas E; Lahesaare A; Truusalu K; Hoidmets D; Sadikova O; Ratnik K; Sepp H; Dotsenko L; Epštein J; Suija H; Kaarna K; Smit S; Milani L; Metspalu M; Oopkaup OE; Koppel I; Jaaniso E; Kuzmin I; Inno H; Raudvere U; Härma MA; Naaber P; Reisberg T; Peterson H; Talas UG; Lutsar I; Huik K
    PLoS One; 2024; 19(5):e0303176. PubMed ID: 38728305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.